Nuvation Bio Inc. (NUVB) — Analysis Summary
Nuvation Bio Inc. (NUVB) has a market cap of $1.79B with year-over-year revenue growth of +699.0%. Net margin stands at -325.3%. The stock trades at a P/E ratio of -12.3.
Key Takeaways
- Revenue changed +699.0% year-over-year
- Net margin of -325.3%
- P/E ratio of -12.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, NUVB posted revenue growth of +699.0% and trades at a P/E of -12.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.